在适当的模型中进行的临床前研究可以帮助确定联合化疗和免疫治疗的最佳时间
Yani Berckmans1, Jolien Ceusters1, Ann Vankerckhoven1
1Department of Oncology, Laboratory of Tumor Immunology and Immunotherapy, Leuven Cancer Institute, KU Leuven, Leuven, Belgium.
Frontiers in immunology
|September 25, 2023
概括
将免疫检查点抑制剂 (ICI) 与化疗相结合,在癌症治疗方面显示出有前途. 优化临床前模型和理解药物测序对于改善临床试验成功和增强抗瘤免疫力至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 癌症研究 癌症研究
背景情况:
- 免疫检查点抑制剂 (ICI) 已经改变了癌症治疗,但对某些癌症的有效性有局限性.
- 与化疗和ICI结合治疗是一个越来越有兴趣的领域,以扩大治疗适用性.
- 许多结合ICI和化疗的临床试验已经产生了低于最佳的结果.
研究的目的:
- 审查现有关于ICI和化疗联合治疗的临床前证据.
- 确定影响这些组合疗法的成功因素.
- 为改善临床前模型和研究设计提供建议.
主要方法:
- 对ICI和化疗组合的现有临床前研究进行系统审查.
- 在临床前模型中分析药物选择,剂量和治疗顺序.
- 对抗瘤免疫力的影响评估和研究结果.
主要成果:
- 关于ICI和化疗组合的临床前数据有限.
- 药物的选择,剂量,以及至关重要的是,服用顺序,显著影响了结果.
- 现有的临床前模型可能无法充分预测临床疗效.
结论:
- 改善临床前模型和研究设计对于成功的临床试验至关重要.
- 确定最佳的药物组合和剂量计划可以增强抗瘤免疫力.
- 战略性临床前评估是最大限度地发挥组合免疫疗法的潜力的关键.
更多相关视频
15:24Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
Published on: December 16, 2022
3.2K
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
11.0K
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:27Tumor Immunotherapy
551
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551
01:30Cancer Vaccines
396
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
396